We are live on ! Find out more
GRNAW

GreenLight Biosciences Holdings, PBC Warrant

Delisted

GRNAW was delisted on the 21st of July, 2023.

1 hedge funds and large institutions have $0 invested in GreenLight Biosciences Holdings, PBC Warrant in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

95% less funds holding

Funds holding: 221 (-21)

95% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 22

100% less capital invested

Capital invested by funds: $83.6K → $0 (-$83.6K)

Holders
1
Holders Change
-21
Holders Change %
-95.45%
% of All Funds
0.02%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
Closed
22
Calls
Puts
Net Calls
Net Calls Change

GRNAW Hedge Fund Activity: Q3 2023 in Review

1 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in GreenLight Biosciences Holdings, PBC Warrant (GRNAW) for Q3 2023, worth a combined $0 — down 100% from $83.6K a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of GRNAW and 1 opened new positions — a net loss of 21 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was Skaana Management, opening a new position worth an estimated $73. The largest seller was LMR Partners, exiting entirely with an estimated $39.1K sold.

  • 1 institutional investor held GreenLight Biosciences Holdings, PBC Warrant (GRNAW) as of Q3 2023, down from 22 in Q2 2023.
  • Funds reported $0 of GreenLight Biosciences Holdings, PBC Warrant stock for Q3 2023, down 100% quarter-over-quarter.
  • 1 fund opened new GreenLight Biosciences Holdings, PBC Warrant positions in Q3 2023 and 22 closed out, a net change of -21 holders.
  • The largest GreenLight Biosciences Holdings, PBC Warrant buyer in Q3 2023 was Skaana Management, an estimated $73 added.
  • The largest GreenLight Biosciences Holdings, PBC Warrant seller in Q3 2023 was LMR Partners, an estimated $39.1K sold.

Based on aggregated 13F filings for Q3 2023.